Titre : 2-Cyano-acrylate d'isobutyle

2-Cyano-acrylate d'isobutyle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Acuity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "2-Cyano-acrylate d'isobutyle : Questions médicales les plus fréquentes", "headline": "2-Cyano-acrylate d'isobutyle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 2-Cyano-acrylate d'isobutyle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enbucrilate", "url": "https://questionsmedicales.fr/mesh/D004659", "about": { "@type": "MedicalCondition", "name": "Enbucrilate", "code": { "@type": "MedicalCode", "code": "D004659", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.051.919.367.341" } } }, "about": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle", "alternateName": "Bucrylate", "code": { "@type": "MedicalCode", "code": "D002015", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael Schultheiß", "url": "https://questionsmedicales.fr/author/Michael%20Schulthei%C3%9F", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Max Giesler", "url": "https://questionsmedicales.fr/author/Max%20Giesler", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lars Maruschke", "url": "https://questionsmedicales.fr/author/Lars%20Maruschke", "affiliation": { "@type": "Organization", "name": "Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Arthur Schmidt", "url": "https://questionsmedicales.fr/author/Arthur%20Schmidt", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lukas Sturm", "url": "https://questionsmedicales.fr/author/Lukas%20Sturm", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mental health and visual acuity in patients with age-related macular degeneration.", "datePublished": "2022-10-02", "url": "https://questionsmedicales.fr/article/36183081", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-022-02602-9" } }, { "@type": "ScholarlyArticle", "name": "Factors associated with visual acuity improvement with a binocular digital therapeutic for amblyopia.", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37611818", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaapos.2023.06.007" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35940177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1752-0024" } }, { "@type": "ScholarlyArticle", "name": "Relationship between dynamic visual acuity and multiple object tracking performance.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35668637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03010066221104281" } }, { "@type": "ScholarlyArticle", "name": "Diurnal Variation of Visual Acuity and Refraction in Fuchs Endothelial Corneal Dystrophy.", "datePublished": "2023-05-08", "url": "https://questionsmedicales.fr/article/37157119", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICO.0000000000003291" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Matériaux biomédicaux et dentaires", "item": "https://questionsmedicales.fr/mesh/D001697" }, { "@type": "ListItem", "position": 5, "name": "Adhésifs tissulaires", "item": "https://questionsmedicales.fr/mesh/D014014" }, { "@type": "ListItem", "position": 6, "name": "Cyanoacrylates", "item": "https://questionsmedicales.fr/mesh/D003487" }, { "@type": "ListItem", "position": 7, "name": "Enbucrilate", "item": "https://questionsmedicales.fr/mesh/D004659" }, { "@type": "ListItem", "position": 8, "name": "2-Cyano-acrylate d'isobutyle", "item": "https://questionsmedicales.fr/mesh/D002015" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 2-Cyano-acrylate d'isobutyle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 2-Cyano-acrylate d'isobutyle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 2-Cyano-acrylate d'isobutyle", "description": "Comment le Bucrylate est-il utilisé en diagnostic ?\nQuels tests sont nécessaires avant d'utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 2-Cyano-acrylate d'isobutyle", "description": "Quels symptômes peuvent survenir après l'application de Bucrylate ?\nLe Bucrylate peut-il provoquer des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 2-Cyano-acrylate d'isobutyle", "description": "Comment prévenir les réactions allergiques au Bucrylate ?\nQuelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 2-Cyano-acrylate d'isobutyle", "description": "Le Bucrylate est-il utilisé pour traiter des infections ?\nComment le Bucrylate favorise-t-il la cicatrisation ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 2-Cyano-acrylate d'isobutyle", "description": "Quelles complications peuvent survenir avec le Bucrylate ?\nLe Bucrylate peut-il causer des réactions systémiques ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 2-Cyano-acrylate d'isobutyle", "description": "Qui est à risque d'allergie au Bucrylate ?\nLes enfants peuvent-ils utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Visual+Acuity&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le Bucrylate est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'est pas utilisé pour le diagnostic, mais pour la fermeture des plaies." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant d'utiliser le Bucrylate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Aucun test spécifique n'est requis, mais l'historique allergique doit être vérifié." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir après l'application de Bucrylate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, démangeaisons ou gonflements peuvent apparaître au site d'application." } }, { "@type": "Question", "name": "Le Bucrylate peut-il provoquer des douleurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs légères peuvent survenir, mais elles sont généralement temporaires." } }, { "@type": "Question", "name": "Comment prévenir les réactions allergiques au Bucrylate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer l'historique allergique et effectuer un test cutané si nécessaire." } }, { "@type": "Question", "name": "Quelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec les yeux et les muqueuses, et utiliser dans un environnement stérile." } }, { "@type": "Question", "name": "Le Bucrylate est-il utilisé pour traiter des infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est utilisé pour la fermeture des plaies, pas pour traiter les infections." } }, { "@type": "Question", "name": "Comment le Bucrylate favorise-t-il la cicatrisation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il forme une barrière protectrice qui aide à maintenir l'humidité et à réduire l'infection." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le Bucrylate ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des réactions allergiques ou des cicatrices anormales peuvent survenir." } }, { "@type": "Question", "name": "Le Bucrylate peut-il causer des réactions systémiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions systémiques sont rares, mais possibles en cas d'allergie sévère." } }, { "@type": "Question", "name": "Qui est à risque d'allergie au Bucrylate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies aux adhésifs ou aux cyanoacrylates." } }, { "@type": "Question", "name": "Les enfants peuvent-ils utiliser le Bucrylate ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais avec prudence et sous supervision médicale en raison de leur peau sensible." } } ] } ] }

Sources (10000 au total)

Mental health and visual acuity in patients with age-related macular degeneration.

Visual acuity (VA) loss has been associated with depression in patients with age-related macular degeneration (AMD). However, previous studies did not incorporate subgroups of AMD when correlating VA ... AMD patients classified by multi-modal imaging were recruited into an AMD registry. Habitual VA was obtained by ophthalmic technicians using the Snellen VA at distance. At enrollment, patients complet... Eight hundred seventy-five patients were included in the study. Patients with bilateral geographic atrophy (GA) or bilateral GA and neovascular (NV) AMD scored lowest on the mental health subscales wi... There is a significant association between mental health questionnaire scores and AMD classification, as well as VA in both the better and worse-seeing eyes in patients with AMD. It is important for c...

Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus.

No information exists on the frequency of visual impairment in people with diabetes mellitus (DM) in Germany. In this study, the prevalence of vision impairment in those individuals was investigated.... We retrospectively analyzed a cohort of 295 people (14221 consultations) at a university outpatient clinic with any type of DM and an available ETDRS-Score and visual acuity. The primary outcome was t... The prevalence of visual impairment in participants with DM was 11.2%; among these individuals, 81.8% had no or non-proliferative retinopathy. In the DM2 subgroup, 81.5% (n=22) of the visually impaire... The prevalence of impaired vision in people with diabetes in our cohort was 11.2%,<20% of visual impairment in people with diabetes is caused by diabetic retinopathy, and 69.7% of participants with vi...

Diurnal Variation of Visual Acuity and Refraction in Fuchs Endothelial Corneal Dystrophy.

Patients with advanced Fuchs endothelial corneal dystrophy frequently report poor vision in the morning, which improves as the day progresses. This study quantified the amount of variation in near and... This was a prospective cohort study. Best-corrected distance visual acuity and near visual acuity were tested in participants with clinically advanced Fuchs dystrophy and in controls with healthy corn... In Fuchs dystrophy, the mean distance visual acuity was worse by -3 letters (95% confidence interval, -4 to -1) directly after eye opening in the morning compared with late afternoon. No such differen... Distance and near visual acuity and refraction changes over the course of the day in patients with advanced Fuchs dystrophy. Although small changes in refraction may not usually require a second set o...

Pupil size effect on binocular summation for visual acuity and light disturbance.

Smaller pupil size under binocular conditions could justify partially the improvement of visual performance when compared to monocular conditions. The purpose of this study was to assess the binocular... Fifteen young subjects were recruited in this crossover study. Light disturbance index (LDI) was evaluated with the light disturbance analyzer and low (LCDVA) and high (HCDVA) contrast visual acuity w... Our results showed poorer visual performance in monocular than the binocular condition. An increasing deterioration was observed with the level of spherical defocus. Positive binocular summation for v... Binocular summation was observed under different conditions of spherical and cylindrical optical degradation of the image quality when the pupil size was fully controlled. This suggests that a neural ...

Impact of induced pseudomyopia and refractive fluctuations of accommodative spasm on visual acuity.

High-contrast visual acuity is disproportionately poor in patients with accommodative spasm subtype of near reflex (SNR-A), relative to uncorrected refractive errors of equivalent magnitude. This exag... To determine how combinations of pseudomyopic refraction and its temporal variations in SNR-A impact high-contrast visual acuity by inducing these patterns in healthy cyclopleged adults, relative to t... Refractive profiles of 15 patients with SNR-A were obtained from a previous study, averaged, and induced before the right eye of 14 cyclopleged adults (mean ±1 SD age: 22.7 ± 2.6 yrs) by feeding the p... The induced refractive fluctuations ranged from -0.80 to -1.75D, around a mean pseudomyopia of -1.20D. Visual acuity deterioration was maximum for the combination of pseudomyopia and temporal fluctuat... Combination of induced pseudomyopia and temporal fluctuations in refraction produces an additive loss of visual acuity and task precision, relative to baseline and each factor considered separately....

Cataract surgery in neovascular AMD: impact on visual acuity and disease activity.

Cataract and neovascular age-related macular degeneration (nAMD) often co-exist and both contribute to impaired vision. It has been debated whether cataract surgery can increase nAMD activity. The pur... Data was obtained from the Swedish Macular Register, the Swedish National Cataract Register, optical coherence tomography (OCT) images and patient charts. All eyes were treated at the Department of Op... In total, 156 patients (168 eyes) were included. The mean age at cataract surgery was 82 (standard deviation, SD 6) years. Both distance and near visual acuity improved after surgery. Distance visual ... Cataract surgery improved visual acuity in patients with on-going treatment for nAMD and did not affect anti-VEGF treatment intensity. Macular morphology remained unchanged. The slight increase in int...